A new CAR comprising tandemly arranged IL-13 and EphA2 single-change variable fragment (scFv), called TanCAR, selectively killed GBM cells by recognizing the IL-13Rα2 or EphA2 alone or together in vitro. Here, IL13RA2 is linked to glioblastoma.